Both a protective and a deleterious role for the L76V mutation

Antimicrob Agents Chemother. 2009 Apr;53(4):1724-5. doi: 10.1128/AAC.01693-08.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / virology
  • Anti-HIV Agents / therapeutic use*
  • Darunavir
  • Drug Resistance, Multiple, Viral / genetics*
  • HIV Protease / genetics*
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1*
  • Humans
  • Lopinavir
  • Mutation*
  • Pyridines / therapeutic use
  • Pyrimidinones / therapeutic use*
  • Pyrones / therapeutic use
  • Sulfonamides / pharmacology

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Pyridines
  • Pyrimidinones
  • Pyrones
  • Sulfonamides
  • Lopinavir
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1
  • Darunavir
  • tipranavir